Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Investigating intratracheal delivery of perfluorocarbon nanoemulsions for photodynamic therapy of lung cancer
EF 2024-25
Résumé
As one of the leading causes of cancer-related deaths, lung cancer remains a complex public health issue that needs to be addressed by new therapeutic approaches. Targeted therapies, such as photodynamic therapy, have the potential to non-invasively treat this disease in its early stages, however, drug delivery through the lung surfactant barrier for local treatment remains a challenge. The utilization of nanotechnology has the potential to overcome this delivery challenge for effective photodynamic therapy applications. Delivering perfluorocarbon-containing nanoemulsions to the lungs via intratracheal administration has been successful in providing magnetic resonance imaging of lung cancer tumors, showing both tumor accumulation and penetration. Engineering nanoemulsions to contain both perfluorocarbons and photosensitizing agents enables photodynamic therapy of lung cancer. With intratracheal administration of these nanoemulsions offering localized delivery to lung tumors, systemic exposure and off-target effects of the agent are minimized, thus offering a significant therapeutic advantage for lung cancer. Successfully bypassing the lung surfactant with nanoemulsions administered intratracheally provides the opportunity to treat early-stage lung cancer with photodynamic therapy and improve the survival prognosis of this disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530326
Name
Loeffen Melissa J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating intratracheal delivery of perfluorocarbon nanoemulsions for photodynamic therapy of lung cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Therapy; Drug Delivery; Drug Discovery; Lung Cancer; Nanoemulsions; Nanotechnology; Perfluorocarbons; Photodynamic Therapy; Targeted Drug Delivery
Abstract
As one of the leading causes of cancer-related deaths, lung cancer remains a complex public health issue that needs to be addressed by new therapeutic approaches. Targeted therapies, such as photodynamic therapy, have the potential to non-invasively treat this disease in its early stages, however, drug delivery through the lung surfactant barrier for local treatment remains a challenge. The utilization of nanotechnology has the potential to overcome this delivery challenge for effective photodynamic therapy applications. Delivering perfluorocarbon-containing nanoemulsions to the lungs via intratracheal administration has been successful in providing magnetic resonance imaging of lung cancer tumors, showing both tumor accumulation and penetration. Engineering nanoemulsions to contain both perfluorocarbons and photosensitizing agents enables photodynamic therapy of lung cancer. With intratracheal administration of these nanoemulsions offering localized delivery to lung tumors, systemic exposure and off-target effects of the agent are minimized, thus offering a significant therapeutic advantage for lung cancer. Successfully bypassing the lung surfactant with nanoemulsions administered intratracheally provides the opportunity to treat early-stage lung cancer with photodynamic therapy and improve the survival prognosis of this disease.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Loeffen, Melissa J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~